CAS 439575-02-7

N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide

CAS: 439575-02-7

Fórmula: C₃₂H₄₁N₅O₄S₂

Pureza: %

Peso molecular: 623.8290

Ref: IN-DA003AJJ

BMS 509744

CAS: 439575-02-7

BMS 509744 is a tyrosine kinase inhibitor. It inhibits the activation of the signal pathways that are involved in the proliferation of t-cells. BMS 509744 has been shown to be effective in inhibiting cancer cells, with a particular focus on T-cell lymphomas. The drug also inhibits inflammation by inhibiting toll-like receptor. This drug has been shown to have an effective dose of 10mg in animal studies and is currently undergoing clinical trials for use against inflammatory diseases, such as rheumatoid arthritis and psoriasis.

Fórmula: C₃₂H₄₁N₅O₄S₂

Pureza: Min. 95%

Peso molecular: 623.83 g/mol

Ref: 3D-PSA57502

BMS-509744

CAS: 439575-02-7

BMS-509744 is a selective, ATP-competitive Itk inhibitor, IC50 of 19 nM. It inhibits IL-8 expression and HIV infection, ameliorates pulmonary inflammation.

Fórmula: C₃₂H₄₁N₅O₄S₂

Pureza: 99.70%

Cor e Forma: Solid

Peso molecular: 623.83

Ref: TM-T14674